Your browser doesn't support javascript.
loading
Long-term overall- and progression-free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non-Hodgkin lymphoma.
Khashab, Tamer; Hagemeister, Fredrick; Romaguera, Jorge E; Fanale, Michelle A; Pro, Barbara; McLaughlin, Peter; Rodriguez, M Alma; Neelapu, Sattva S; Fayad, Luis; Younes, Anas; Feng, Lei; Vega, Francisco; Kwak, Larry W; Samaniego, Felipe.
Afiliação
  • Khashab T; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hagemeister F; Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA, USA.
  • Romaguera JE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fanale MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pro B; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McLaughlin P; Seattle Genetics, Inc., Bothell, WA, USA.
  • Rodriguez MA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Neelapu SS; Robert H Lurie Medical Research Center, Chicago, IL, USA.
  • Fayad L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Younes A; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feng L; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Vega F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kwak LW; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Samaniego F; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Br J Haematol ; 185(4): 670-678, 2019 05.
Article em En | MEDLINE | ID: mdl-30820940

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Linfocítica Crônica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos